Comparison
18q Partial Monosomy Syndrome C0265472 vs 2 Hydroxyphenylacetic Aciduria C5937087
Clinical comparison between 18q Partial Monosomy Syndrome and 2 Hydroxyphenylacetic Aciduria for differential diagnosis and treatment planning.
18q Partial Monosomy Syndrome C0265472
A chromosomal disorder involving deletion of part of chromosome 18. Causes developmental delays, intellectual disability, and various physical features. Treatment focuses on managing specific symptoms.
2 Hydroxyphenylacetic Aciduria C5937087
A rare metabolic disorder where the body cannot properly process certain acids. It may cause neurological issues and is typically identified in infancy. Management involves diet modifications and supportive care.
6 comparison axes
Onset
18q Partial Monosomy Syndrome C0265472
0-0
2 Hydroxyphenylacetic Aciduria C5937087
0-null
Onset patterns differ
Severity
18q Partial Monosomy Syndrome C0265472
severe
2 Hydroxyphenylacetic Aciduria C5937087
moderate
Different severity levels
Chronic
18q Partial Monosomy Syndrome C0265472
Chronic
2 Hydroxyphenylacetic Aciduria C5937087
Chronic
Differing course
Communicable
18q Partial Monosomy Syndrome C0265472
No
2 Hydroxyphenylacetic Aciduria C5937087
No
Different transmission
Body System
18q Partial Monosomy Syndrome C0265472
congenital
2 Hydroxyphenylacetic Aciduria C5937087
metabolic
Same/different system
Category
18q Partial Monosomy Syndrome C0265472
genetic
2 Hydroxyphenylacetic Aciduria C5937087
metabolic
Different category
Bottom line
18q-partial-monosomy-syndrome-C0265472 and 2-hydroxyphenylacetic-aciduria-C5937087 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 18q Partial Monosomy Syndrome C0265472 | 2 Hydroxyphenylacetic Aciduria C5937087 | Discriminating power |
|---|---|---|---|
| Developmental pattern | Congenital developmental delay and intellectual disability are described. | Neurological issues may occur, often recognized in infancy; not definitive. | Moderate |
| Physical features | Various congenital physical features may accompany the deletion. | No characteristic physical pattern is established in the source data. | Moderate |
| Metabolic presentation | Not primarily described as an organic aciduria. | Impaired processing of certain acids with aciduria is the defining concern. | High |
When to favor each condition
Choose 18q Partial Monosomy Syndrome C0265472 when
Congenital multisystem features
A chromosomal deletion better fits congenital developmental and physical findings.
Moderate
Known chromosome 18 deletion
Genetic confirmation supports the left concept over a metabolic finding.
High
Severe lifelong developmental disorder
Source severity is severe and congenital, though individual course varies.
Moderate
Choose 2 Hydroxyphenylacetic Aciduria C5937087 when
Abnormal organic acid result
Aciduria points toward a metabolic abnormality needing confirmation.
Moderate
Infantile neurological concern without dysmorphism
Source data emphasize infancy and possible neurological issues.
Low
Dietary response is being considered
Management is described as diet modification and supportive care, not a dose.
Low
How key tests differ
| Test | 18q Partial Monosomy Syndrome C0265472 | 2 Hydroxyphenylacetic Aciduria C5937087 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | Partial deletion of chromosome 18 may be identified. | Not expected to establish this aciduria. | A positive deletion supports the left diagnosis; absence does not explain aciduria. |
| Urine organic acid analysis | No specific aciduria pattern is established here. | Elevated 2-hydroxyphenylacetic acid may be reported; cutoff not supplied. | Treat as an abnormal result until a clinician confirms its cause. |
| Developmental assessment | Delays and intellectual disability are commonly assessed. | Neurological effects may be assessed, but are not definitive. | Assessment guides support needs and does not distinguish etiology alone. |
Prognosis comparison
18q Partial Monosomy Syndrome C0265472
- Outcome
- Often a severe chronic congenital condition; exact outcomes vary and are not quantified here.
- Factors
- Deletion extent, associated anomalies, developmental support, and comorbidities.
2 Hydroxyphenylacetic Aciduria C5937087
- Outcome
- Described as moderate and chronic, but prognosis is not established from these data.
- Factors
- Degree of metabolic abnormality, neurological involvement, diet, and supportive care.
Time frame: Lifelong follow-up may be needed; onset is congenital or infantile.
Neither condition is communicable; individual prognosis requires specialist assessment.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurodevelopment | Developmental delay and intellectual disability are core concerns. Possible neurological issues; extent is not established. Both may need developmental follow-up, but causes differ. |
| Congenital anomalies | Physical features may require specialty care. Not established as a congenital malformation syndrome. Do not infer specific anomalies without evaluation. |
| Metabolic decompensation | Not described as the main complication. Acid-processing difficulty may need dietary and supportive management. Exact triggers, thresholds, and outcomes are not established. |
Patient education highlights
- HighDifferent causes
One is a chromosome 18 deletion; the other is a rare acid-processing abnormality or test finding.
- HighConfirmation
Genetic or metabolic results need clinician interpretation before labeling a diagnosis.
- MediumSupportive care
Care targets individual symptoms, development, nutrition, and associated medical needs.